Why the Dose and Interval Are Separate Decisions
When renal impairment lowers drug clearance, the same dose given at the same interval generally produces greater average exposure. A common first calculation is to reduce the dose rate to account for the lower clearance. But the dose rate can be reduced in more than one way: give a smaller dose at the original interval, or give the original dose less often. These options can match average exposure while producing different peaks, troughs, and time spent in a target concentration range.
That distinction matters when an effect depends on maintaining concentrations above a threshold, or when toxicity is associated with high peaks. It also matters when the chosen endpoint is an exposure measure such as AUC rather than a particular concentration. The comparison below isolates these consequences under a simple, explicit model; actual regimen recommendations require checking that its assumptions are suitable for the drug and population.
Steady-State Exposure and Accumulation
Between doses, concentration declines exponentially. At steady state, the concentration just after a dose is the new dose contribution plus the residual concentration from all earlier doses. Summing the geometric series of residual contributions gives the peak concentration. The trough is the peak after one interval of elimination.
The factor \(R=1/(1-e^{-k\tau})\) is the accumulation ratio for the post-dose concentration relative to the concentration increment from one dose, \(D/V\). As \(k\tau\) becomes smaller, more drug remains when the next dose is given, so accumulation increases. The peak-to-trough ratio is \(e^{k\tau}\); a larger value means greater within-interval fluctuation.
AUC over one steady-state interval follows by integrating the exponential decline from the peak to the trough. The following derivation also shows why AUC per interval depends on dose and clearance, not on how much accumulation occurs.
The average concentration over an interval is therefore \(\mathrm{AUC}_{\tau}/\tau=D/(CL\tau)\). If renal impairment reduces clearance to a fraction \(f\) of its original value, with \(0<f<1\), then maintaining the same average concentration under this linear model requires reducing the dose rate \(D/\tau\) to fraction \(f\) of its former value. One option is to reduce \(D\) by \(f\) while keeping \(\tau\) fixed; another is to increase \(\tau\) by \(1/f\) while keeping \(D\) fixed. They match average exposure, but need not match peaks, troughs, or the concentration-time profile.
Worked Example: Comparing Two Exposure-Matched Regimens
Consider a hypothetical drug given by intravenous bolus. Before renal impairment, let \(CL=4.00\) L/h, \(V=40.0\) L, and the regimen be 400 mg every 12 h. Suppose renal impairment lowers clearance to 2.00 L/h without changing \(V\). Compare reducing the dose to 200 mg every 12 h with extending the interval to 24 h while retaining the 400 mg dose.
Baseline average concentration. Initially, \(k=4.00/40.0=0.100\ \mathrm{h}^{-1}\), and the average concentration is \(\bar{C}=D/(CL\tau)=400/(4.00\times12)=8.333\) mg/L.
Reduced dose every 12 h. With impaired clearance, \(k=2.00/40.0=0.0500\ \mathrm{h}^{-1}\). The AUC per interval is \(200/2.00=100\) mg·h/L, so the average remains \(100/12=8.333\) mg/L. Here \(k\tau=0.600\), \(e^{-0.600}=0.548812\), and \(D/V=200/40.0=5.00\) mg/L. Thus \(C_{\max,\mathrm{ss}}=5.00/(1-0.548812)=11.082\) mg/L and \(C_{\min,\mathrm{ss}}=11.082(0.548812)=6.082\) mg/L.
Original dose every 24 h. The AUC per interval is \(400/2.00=200\) mg·h/L, and the average is \(200/24=8.333\) mg/L. Now \(k\tau=1.200\), \(e^{-1.200}=0.301194\), and \(D/V=10.0\) mg/L. Therefore, \(C_{\max,\mathrm{ss}}=10.0/(1-0.301194)=14.310\) mg/L and \(C_{\min,\mathrm{ss}}=14.310(0.301194)=4.310\) mg/L.
Both regimens match the baseline average concentration in this model. The smaller, more frequent dose gives a lower peak and higher trough than the larger, less frequent dose. Average exposure alone does not establish that either profile is preferable.
Worked Example: Checking a Steady-State Trough Calculation
For a hypothetical bolus regimen, suppose each dose contributes \(D/V=7.500\) mg/L immediately after administration and \(k\tau=0.900\). Calculate the steady-state trough.
The steady-state trough formula gives \(C_{\min,\mathrm{ss}}=7.500e^{-0.900}/(1-e^{-0.900})\). Using \(e^{-0.900}=0.406570\), the numerator is \(7.500(0.406570)=3.04928\) mg/L and the denominator is \(1-0.406570=0.593430\). The quotient is \(3.04928/0.593430=5.1384\) mg/L, which rounds to 5.138 mg/L. This value is the concentration immediately before the next dose at steady state, not the concentration after a single dose.
Match the Regimen to the Concentration-Dependent Objective
When two regimens have the same average exposure, a concentration-based objective can still distinguish them. For instance, a minimum-concentration target may favour a higher trough, while a peak-related toxicity limit may favour a lower peak. Such targets are drug- and context-specific; they should not be treated as universal criteria. The next example uses deliberately hypothetical limits to show how to make the comparison transparently.
Worked Example: Applying Illustrative Peak and Trough Targets
Use the two exposure-matched regimens from the previous example. Suppose, for illustration only, that the efficacy objective is a steady-state trough of at least 5.0 mg/L and the toxicity objective is a peak no greater than 13.0 mg/L.
For 200 mg every 12 h, the calculated trough is 6.082 mg/L, which exceeds 5.0 mg/L, and the peak is 11.082 mg/L, which is below 13.0 mg/L. This regimen meets both illustrative criteria.
For 400 mg every 24 h, the trough is 4.310 mg/L, below the illustrative efficacy target, and the peak is 14.310 mg/L, above the illustrative toxicity limit. It meets neither criterion. The example does not establish a clinical recommendation: it shows that equal average concentration does not guarantee equal target attainment, and the numerical targets would need drug-specific support.
For a drug whose effect is related to time above a threshold, trough alone may be insufficient. In the bolus model, if \(C_{\min,\mathrm{ss}}<C_{\mathrm{thr}}<C_{\max,\mathrm{ss}}\), the time above threshold during one interval is \(\ln(C_{\max,\mathrm{ss}}/C_{\mathrm{thr}})/k\). If the trough is at or above the threshold, the entire interval is above it; if the peak is at or below the threshold, none of the interval is above it.
Worked Example: Comparing Time Above a Hypothetical Threshold
Suppose the hypothetical efficacy measure is the fraction of each interval above 7.0 mg/L. For the 200 mg every 12 h regimen, the peak is 11.082 mg/L and \(k=0.0500\ \mathrm{h}^{-1}\). Its trough is below 7.0 mg/L, so time above threshold is \(\ln(11.082/7.0)/0.0500=9.19\) h, or \(9.19/12=76.6\%\) of the interval.
For 400 mg every 24 h, the peak is 14.310 mg/L, and the trough is also below 7.0 mg/L. Time above threshold is \(\ln(14.310/7.0)/0.0500=14.30\) h, or \(14.30/24=59.6\%\) of the interval. The extended-interval regimen spends more absolute hours above the threshold, but a smaller fraction of its longer interval. Thus the relevant comparison depends on the efficacy metric, not simply on the number of hours above threshold.
Assumptions, Diagnostics, and Alternatives
The calculations rely on linear, time-invariant elimination and a one-compartment representation. They also presume that the renal change is adequately represented as a clearance change, and that the dose reaches the modeled compartment as assumed. If clearance changes over time, dose proportionality fails, distribution is multicompartmental, or absorption is slow, the simple peak and trough equations may not describe the observed profile. AUC relationships may still be useful under broader conditions, but they should be derived from an appropriate model rather than assumed from these bolus expressions.
Check model-based predictions against concentration-time profiles and the population model used for the dosing question. In particular, inspect whether predicted peaks and troughs are plausible, whether the sampling times can distinguish the profile shape, and whether the assumed steady state is reasonable. Because renal impairment can lengthen the half-life \(t_{1/2}=\ln(2)/k\), reaching steady state may take longer. Applying steady-state equations to concentrations measured during wash-in can misrepresent accumulation.
The main alternatives answer different questions. Matching dose rate to clearance is a useful starting point for matching average exposure; comparing \(C_{\max,\mathrm{ss}}\), \(C_{\min,\mathrm{ss}}\), or time above a threshold evaluates profile-dependent objectives. A model-based simulation can compare whole concentration-time profiles and variability across individuals when the simple equations are inadequate. None of these approaches removes the need to justify the pharmacodynamic target or to check whether the model applies to the intended population.
| Approach | What it emphasizes | Main caution |
|---|---|---|
| Reduce dose, retain interval | Lower dose per administration; often a higher trough and smaller peak–trough swing than interval extension at matched average exposure | May not suit a drug whose efficacy depends on a high peak |
| Retain dose, extend interval | Fewer administrations; can preserve average exposure when the interval is lengthened in proportion to the clearance reduction | Can create lower troughs and longer periods below an efficacy threshold |
| Compare simulated concentration-time profiles | Evaluates a chosen exposure or pharmacodynamic metric across modeled individuals | Depends on model adequacy, assumptions, and correct implementation |
Common pitfall: “Clearance is halved, so either half the dose or twice the interval gives the same concentrations.” The correction is that these choices can give the same average concentration under linear kinetics, but the profile is not generally the same. In the worked comparison, dose reduction produced a trough of 6.082 mg/L and peak of 11.082 mg/L, whereas interval extension produced a trough of 4.310 mg/L and peak of 14.310 mg/L. Similarity in average exposure is not equivalence in peak, trough, or time above a target.
Check Your Understanding
Answer each question, then compare your reasoning with the solutions.
- If clearance is reduced to 75% of its original value and \(V\) is unchanged, what dose-rate adjustment preserves average concentration under the linear model?
- Why can dose reduction and interval extension preserve average concentration yet produce different troughs?
- For a bolus regimen with \(C_{\max,\mathrm{ss}}=12\) mg/L, \(C_{\min,\mathrm{ss}}=4\) mg/L, and \(\tau=8\) h, is the entire interval above a threshold of 5 mg/L?
- Name two assumptions that could make the bolus equations unsuitable for predicting a drug’s concentration profile.
Solutions. (1) Reduce dose rate to 75% of its original value. For example, reduce dose to 75% at the same interval, or increase the interval by \(1/0.75=1.333\) at the same dose, subject to the model assumptions. (2) The two strategies change \(k\tau\) and/or the dose increment \(D/V\) differently, changing accumulation and within-interval decline even when \(D/(CL\tau)\) is matched. (3) No. The trough is 4 mg/L, below 5 mg/L, so concentration falls below the threshold before the next dose. (4) Examples include delayed absorption, multicompartment distribution, or time-varying or nonlinear elimination.